Tech Company Financing Transactions

Numira Biosciences Funding Round

Signal Peak Ventures participated in a $2.3 million funding round for Numira Biosciences. The round was announced on 3/31/2009.

Transaction Overview

Company Name
Announced On
3/31/2009
Transaction Type
Venture Equity
Amount
$2,254,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
560 Arapeen Drive 250
Salt Lake City, UT 84108
USA
Email Address
Overview
Numira is a specialty R&D tools company focused on leveraging advances in genetics and in vivo molecular imaging to create a catalog of products that will provide researchers with unprecedented insight into drug discovery and genomics.
Profile
Numira Biosciences LinkedIn Company Profile
Social Media
Numira Biosciences Company Twitter Account
Company News
Numira Biosciences News
Facebook
Numira Biosciences on Facebook
YouTube
Numira Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Hal Widlansky
  Hal Widlansky LinkedIn Profile  Hal Widlansky Twitter Account  Hal Widlansky News  Hal Widlansky on Facebook
Chief Technical Officer
David Weinstein
  David Weinstein LinkedIn Profile  David Weinstein Twitter Account  David Weinstein News  David Weinstein on Facebook
VP - Sales
David Raminick
  David Raminick LinkedIn Profile  David Raminick Twitter Account  David Raminick News  David Raminick on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2009: Seizert Capital Partners venture capital transaction
Next: 3/31/2009: Simple Garden venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on all VC transactions involving tech companies. VC transactions on this site are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary